Other OTC - Delayed Quote • USD
VG Life Sciences Inc. (VGLS)
At close: April 25 at 3:59 PM EDT
Breakdown
TTM
Operating Expense
2,726.6410
Operating Income
-2,726.6410
Net Non Operating Interest Income Expense
-2,062.9580
Other Income Expense
456.4750
Pretax Income
-4,333.1240
Net Income Common Stockholders
-4,298.7160
Diluted NI Available to Com Stockholders
-4,298.7160
Basic EPS
-0.04
Diluted EPS
-0.04
Basic Average Shares
60,433.9510
Diluted Average Shares
60,433.9510
Total Operating Income as Reported
-2,726.6410
Total Expenses
2,726.6410
Net Income from Continuing & Discontinued Operation
-4,298.7160
Normalized Income
-4,755.1910
Interest Expense
2,062.9580
Net Interest Income
-2,062.9580
EBIT
-2,270.1660
EBITDA
-2,270.1660
Net Income from Continuing Operation Net Minority Interest
-4,298.7160
Total Unusual Items Excluding Goodwill
456.4750
Total Unusual Items
456.4750
Normalized EBITDA
-2,726.6410
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BAYP Bayport International Holdings, Inc.
0.0003
0.00%
XTRM Extreme Biodiesel, Inc.
0.0000
0.00%
GGEI Green Giant Inc.
0.0037
-0.94%
GDC.TO Genesis Land Development Corp.
3.1500
-3.08%
SDHC Smith Douglas Homes Corp.
25.84
-3.08%
MRNO Murano Global Investments Plc
7.86
+4.38%
SGD Safe and Green Development Corporation
0.6572
+3.99%